Terms: = Head and neck cancer AND CgA AND Prognosis
21 results:
1. Identification of an 8 HPV-related RNA signature as a novel prognostic biomarker for squamous cell carcinoma of the head and neck.
Mei Z; Zhengdong L; Shupeng L; Xin Z; Lei W; Wang C
Medicine (Baltimore); 2024 Feb; 103(6):e36448. PubMed ID: 38335428
[TBL] [Abstract] [Full Text] [Related]
2. Clinicopathological features, treatment modalities, and prognosis of esophageal neuroendocrine carcinoma: A single-center retrospective study.
Zhang Y; Liao JT; Lin Y; Liu C; Wu ZH; Yu B; Sun S; Yu H; Hui XH; Wu XH; Zhao XM; Wang HJ; Zheng Q; Li Y; Hu ZH; Wang JL
J Dig Dis; 2023; 24(8-9):472-479. PubMed ID: 37596865
[TBL] [Abstract] [Full Text] [Related]
3. Preoperative Comprehensive Geriatric Assessment Predicts Postoperative Risk in Older Patients with Esophageal cancer.
Yamashita K; Yamasaki M; Makino T; Tanaka K; Saito T; Yamamoto K; Takahashi T; Kurokawa Y; Yasunobe Y; Akasaka H; Rakugi H; Nakajima K; Eguchi H; Doki Y
Ann Surg Oncol; 2023 Feb; 30(2):901-909. PubMed ID: 36367627
[TBL] [Abstract] [Full Text] [Related]
4. [Nasopharyngeal carcinoma with non-squamous immunophenotype: a clinicopathological analysis of 23 cases].
Wang JH; Zhu H; Shang YF; Wang YJ; Li Y; Wang L; Huang SS; Lyu XQ
Zhonghua Bing Li Xue Za Zhi; 2022 Jun; 51(6):500-505. PubMed ID: 35673720
[No Abstract] [Full Text] [Related]
5. cancer germline antigen gene MAGEB2 promotes cell invasion and correlates with immune microenvironment and immunotherapeutic efficiency in laryngeal cancer.
Cui J; Chen Y; Ou Y; Liu G; Wen Q; Zhu W; Liang L; Chen Z; Yang H; Wang L; Wei M
Clin Immunol; 2022 Jul; 240():109045. PubMed ID: 35618211
[TBL] [Abstract] [Full Text] [Related]
6. Utilizing the circulating tumor markers in diagnosis and management of medullary thyroid cancer.
Zarkesh M; Arab N; Tavangar SM; Nozhat Z; Fanaei SM; Hedayati M
Pathol Res Pract; 2022 Jan; 229():153694. PubMed ID: 34929598
[TBL] [Abstract] [Full Text] [Related]
7. [Clinicopathological characteristics of SMARCB1(INI1)-deficient sinonasal carcinoma].
Wang JY; Bai YP; Xing L; Piao YS; He XJ; Yue CL; Zhao XL; Liu HG
Zhonghua Bing Li Xue Za Zhi; 2021 Nov; 50(11):1240-1245. PubMed ID: 34719161
[No Abstract] [Full Text] [Related]
8. Basic Pan-cancer Analysis of the Carcinogenic Effects of Cyclin-Dependent Kinase 4 (CDK4) in Human Surface Tumors.
Wu J; Deng T; Huang Y; Cheng H
J Healthc Eng; 2021; 2021():8493572. PubMed ID: 34422248
[TBL] [Abstract] [Full Text] [Related]
9. Parathyroid carcinoma with sarcomatoid differentiation: a case report and literature review.
Hu L; Xie X
Diagn Pathol; 2020 Dec; 15(1):142. PubMed ID: 33317559
[TBL] [Abstract] [Full Text] [Related]
10. Clinicopathological features of low-grade malignant endolymphatic sac tumors.
Wang HQ; Jie L; Shi HY
Pathol Res Pract; 2018 Mar; 214(3):431-435. PubMed ID: 29482989
[TBL] [Abstract] [Full Text] [Related]
11. Characterization of tissue chromogranin A (cga) immunostaining and clinicohistopathological changes for the 125 Chinese patients with primary small cell carcinoma of the esophagus.
Ku JW; Zhang DY; Song X; Li XM; Zhao XK; Lv S; Hu SJ; Cheng R; Zhou FY; Wu HF; Wang LD
Dis Esophagus; 2017 Aug; 30(8):1-7. PubMed ID: 28575250
[TBL] [Abstract] [Full Text] [Related]
12. [Utility of NUT gene expression and rearrangement in diagnosis of NUT midline carcinoma in upper respiratory tract].
Fang W; French CA; Cameron MJ; Han YD; Liu HG
Zhonghua Bing Li Xue Za Zhi; 2012 Aug; 41(8):519-24. PubMed ID: 23157742
[TBL] [Abstract] [Full Text] [Related]
13. Malignant mesenchymoma of the thyroid: case report and literature review.
Shi H; Wang C; Wei L; Lu S; Cao D
Tumori; 2010; 96(2):345-8. PubMed ID: 20572598
[TBL] [Abstract] [Full Text] [Related]
14. The surgical strategy and the molecular analysis of patients with parathyroid cancer.
Enomoto K; Uchino S; Ito A; Watanabe S; Shibuya H; Enomoto Y; Noguchi S
World J Surg; 2010 Nov; 34(11):2604-10. PubMed ID: 20480190
[TBL] [Abstract] [Full Text] [Related]
15. Superficial primary small cell carcinoma of the esophagus: clinicopathological and immunohistochemical analysis of 15 cases.
Lu J; Xue LY; Lu N; Zou SM; Liu XY; Wen P
Dis Esophagus; 2010 Feb; 23(2):153-9. PubMed ID: 19515193
[TBL] [Abstract] [Full Text] [Related]
16. Primary small cell carcinoma of the esophagus: clinicopathological and immunohistochemical features of 21 cases.
Yun JP; Zhang MF; Hou JH; Tian QH; Fu J; Liang XM; Wu QL; Rong TH
BMC Cancer; 2007 Mar; 7():38. PubMed ID: 17335582
[TBL] [Abstract] [Full Text] [Related]
17. The biological characteristics of chromogranin A and its role as a circulating marker in neuroendocrine tumours.
Ferrari L; Seregni E; Bajetta E; Martinetti A; Bombardieri E
Anticancer Res; 1999; 19(4C):3415-27. PubMed ID: 10629629
[TBL] [Abstract] [Full Text] [Related]
18. Chromogranin A measurement in neuroendocrine tumors.
Ferrari L; Seregni E; Martinetti A; Van Graafeiland B; Nerini-Molteni S; Botti C; Artale S; Cresta S; Bombardieri E
Int J Biol Markers; 1998; 13(1):3-9. PubMed ID: 9681293
[TBL] [Abstract] [Full Text] [Related]
19. Establishment of anaplastic thyroid carcinoma cell lines useful for analysis of chemosensitivity and carcinogenesis.
Asakawa H; Kobayashi T; Komoike Y; Yanagawa T; Takahashi M; Wakasugi E; Maruyama H; Tamaki Y; Matsuzawa Y; Monden M
J Clin Endocrinol Metab; 1996 Oct; 81(10):3547-52. PubMed ID: 8855799
[TBL] [Abstract] [Full Text] [Related]
20. p53 gene mutation in thyroid carcinoma.
Ho YS; Tseng SC; Chin TY; Hsieh LL; Lin JD
Cancer Lett; 1996 May; 103(1):57-63. PubMed ID: 8616809
[TBL] [Abstract] [Full Text] [Related]
[Next]
